Tag Archives: cancer

Bristol Myers Squibb’s Opdivo cuts relapse risk in muscle-invasive bladder cancer

Bristol Myers Squibb’s Opdivo has plenty of competition in its current bladder cancer indication—so it’s hoping to strike out on its own in a new area of the disease. The company revealed Thursday that its PD-1 fighter, against placebo, had lengthened the time muscle-invasive urothelial carcinoma patients could remain disease-free after surgery. All patients saw benefit,… Read More »

Hormonal treatments for prostate cancer are often given late

Men with advanced prostate cancer are typically treated with drugs that cause testosterone levels to plummet. Testosterone is a hormone that fuels growing prostate tumors, so ideally this type of treatment, which is called androgen deprivation therapy (ADT), or hormonal therapy, will stall the disease in its tracks. For that to happen, ADT has to… Read More »

Merck’s Keytruda sets up Opdivo showdown with esophageal cancer victory

After archrival Opdivo from Bristol-Myers Squibb posted a pair of esophageal cancer wins last week, Merck & Co.’s Keytruda is determined not to be left behind. The New Jersey drugmaker Wednesday said a combination of its PD-1 blockbuster plus chemo had topped chemo at keeping cancer at bay and extending patients’ lives in a trial… Read More »

Bayer reaches over $10 billion settlement in Roundup cancer lawsuits

Roundup weed killing products are offered for sale at a home improvement store on May 14, 2019 in Chicago, Illinois. Scott Olson | Getty Images Bayer will pay more than $ 10 billion to resolve thousands of lawsuits regarding claims that its herbicide Roundup causes cancer, the company announced Wednesday. Monsanto, which Bayer bought in 2018,… Read More »